Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01746134 · ClinicalTrials.gov registry record

The Management of Schizophrenia in Clinical Practice (MOSAIC)

A clinical trial of Schizophrenia, sponsored by Genentech.

Completed
Registry status
557
Enrollment target
20
Study locations

NCT01746134 is a study of Schizophrenia that has completed, run by Genentech. The registered enrollment target is 557 participants, above the 217-participant average among 315 other Schizophrenia trials with a reported enrollment target (157% higher). The trial reports 20 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01746134, a study of Schizophrenia, has completed, sponsored by Genentech.

COMPLETED
Registry status
557 participants
Enrollment target
20
Study locations

Study Summary

This study is a disease-based registry designed to follow patients with a DSM-IV-TR (Diagnostic and Statistic Manual of Mental Disorders, Text Revision) diagnosis of schizophrenia, schizoaffective disorder, or schizophreniform disorder treated in usual care settings for up to 5 years. The registry seeks to describe the course of disease in schizophrenia, including cognitive function and negative symptoms, its treatment, and its burden of disease for participants, caregivers, clinicians, and society as a whole.

Conditions Studied

Schizophrenia

Study Locations (20)

Florida

  • - Chicago
  • - Gainesville
  • - Gainesville
  • - Gainesville
  • - Jacksonville
  • - Lake City
  • - Miami
  • - Miami

California

  • - Granada Hills
  • - Los Angeles
  • - Santa Monica

Iowa

  • - Iowa City
  • - Iowa City
  • - Iowa City

Connecticut

  • - Cedar Rapids
  • - New Haven

Minnesota

  • - Minneapolis
  • - Saint Paul

Illinois

  • - Chicago

Massachusetts

  • - Belmont

Trial Details

FieldValue
Enrollment Target 557 participants
Start Date 2012-12
Est. Completion 2014-05

Sponsor

Genentech

332 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01746134

The ClinicalTrials.gov registry entry for NCT01746134 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 557 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 217-participant average among 315 other Schizophrenia trials with a reported enrollment target (157% higher). The listed sponsor is Genentech, which has 332 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 0 interventions.

NCT01746134 reports 20 study locations spanning 7 distinct geographic areas - top geographies include Florida, California, Iowa.

Frequently Asked Questions

What is clinical trial NCT01746134 about?

NCT01746134 is a clinical study titled "The Management of Schizophrenia in Clinical Practice (MOSAIC)". This study is a disease-based registry designed to follow patients with a DSM-IV-TR (Diagnostic and Statistic Manual of Mental Disorders, Text Revision) diagnosis of schizophrenia, schizoaffective disorder, or schizophreniform disorder treated in usual care settings for up to 5 years. The registry s...

What is the current status of trial NCT01746134?

This trial is currently completed. The enrollment target is 557 participants. The study started on 2012-12. Estimated completion is 2014-05.

What conditions does trial NCT01746134 study?

This clinical trial studies the following conditions: Schizophrenia.

Who is sponsoring clinical trial NCT01746134?

This trial is sponsored by Genentech, which has 332 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01746134 being conducted?

This trial has 20 study locations across California, Connecticut, Florida, Illinois, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Schizophrenia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.